Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119219) titled 'Efficacy and safety of Tegileridine in intravenous analgesia for oral tumors: a multicenter, randomized, double-blind, positive-controlled clinical study' on Feb. 24.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Condition:
Postoperative pain in patients undergoing oral tumor surgery
Intervention:
Morphine hydrochloride Group:Postoperative continuous intravenous analgesia with Morphine hydrochloride
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-03-01
Target Sampl...